Selective Serotonin Reuptake Inhibitor (SSRI) updated on 07-01-2025

Neonatal medical care

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18442
R78281
Lee (Controls exposed to TCAs), 2025 Admission to neonatal intensive care unit (NICU) during pregnancy (anytime or not specified) retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No Monotherapy: SSRI only 0.81 [0.48;1.39] C
excluded (control group)
41/1,465   21/613 62 1,465
ref
S18408
R77703
Lee (Controls unexposed, general pop), 2025 Admission to neonatal intensive care unit (NICU) during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 1.03 [0.74;1.43] 41/1,465   8,566/463,440 8,607 1,465
ref
S18131
R76225
Raviv, 2025 Neonatal intensive care unit admission (NICU) during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 3.07 [2.59;3.65] C 150/2,321   2,278/103,607 2,428 2,321
ref
S18258
R76640
Cornet - SSRIs, 2024 Delayed neonatal adaptation (presence of at least one of the following: 5min Apgar score ≤5; positive pressure ventilation or intubation during delivery room resuscitation; or admission to the NICU with respiratory distress requiring invasive or non-invasive ventilation) late pregnancy retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Monotherapy: no or not specified 2.14 [1.96;2.33] 847/7,573   12,078/272,517 12,925 7,573
ref
S14988
R61341
Gover, 2023 Delivery room advanced resuscitation throughout pregnancy retrospective cohort unexposed (general population or NOS) Adjustment: No Matched Monotherapy: no or not specified 1.58 [0.24;10.61] C 3/21   2/21 5 21
ref
S18233
R76476
Rommel, 2022 Neonatal admission (inpatient contact with the first 28 days, excluding contact with the ICD-10 Z38 or Z76) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: Yes Monotherapy: SSRI only Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) 1.43 [1.35;1.51] -/16,429   -/23,676 - 16,429
ref
S13112
R49960
Marks - Sertraline (Controls exposed to Bupropion), 2021 Neonatal intensive care unit admission during pregnancy (anytime or not specified) retrospective cohort exposed to other treatment, sick Adjustment: Yes Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) 1.08 [0.81;1.45] 384/1,653   91/406 475 1,653
ref
S10057
R36520
Ulbrich, 2021 Neonatal intensive care unit (NICU) admission 3rd trimester retrospective cohort unexposed (general population or NOS) Adjustment: Yes Monotherapy: no or not specified 2.13 [1.18;3.32] 20/163   282/4,770 302 163
ref
S5461
R24127
Levy, 2020 Neonatal intensive care unit throughout pregnancy retrospective cohort unexposed (general population or NOS) Adjustment: No Matched Monotherapy: no or not specified 8.34 [3.78;18.39] C 44/82   10/82 54 82
ref
S12918
R49003
Gungor (Controls exposed to Mirtazapine), 2019 Staying at Neonatal Intensive Care Unit (NCU) during pregnancy (anytime or not specified) prospective cohort exposed to other treatment, sick excluded Adjustment: No Monotherapy: SSRI only 1.48 [0.27;8.06] C
excluded (control group)
7/40   2/16 9 40
ref
S8158
R25130
Gungor (Controls unexposed, disease free), 2019 Staying at Neonatal Intensive Care Unit (NCU) during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: No Monotherapy: SSRI only 0.48 [0.15;1.62] C
excluded (control group)
7/40   7/23 14 40
ref
S8159
R25136
Gungor (Controls unexposed, sick), 2019 Staying at Neonatal Intensive Care Unit (NCU) during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No Monotherapy: SSRI only Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified 1.41 [0.33;6.10] C 7/40   3/23 10 40
ref
S7921
R23970
Giardinelli (Controls unexposed, disease free), 2018 Neonatal intensive care unit during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: No Monotherapy: no or not specified 5.93 [0.27;130.35] C
excluded (control group)
2/24   0/26 2 24
ref
S7916
R23961
Giardinelli (Controls unexposed, sick), 2018 Neonatal intensive care unit during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 0.95 [0.12;7.41] C 2/24   2/23 4 24
ref
S7569
R22727
Hogue, 2017 Neonatal Intensive Care Unit admission (in full-term neonates) during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 4.90 [1.30;18.70] 16/117   4/116 20 117
ref
S10062
R36569
Bracero, 2016 Neonatal intensive care unit (NICU) admissions days before delivery retrospective cohort unexposed, sick Adjustment: No Monotherapy: no or not specified 12.17 [2.00;73.89] C 4/6   12/85 16 6
ref
S7570
R22768
Kivistö, 2016 Neonatal intensive care during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 2.20 [1.67;2.88] 82/358   2,431/24,402 2,513 358
ref
S5430
R16579
Norby, 2016 Admission to Neonatal intensive care unit 3rd trimester population based cohort retrospective unexposed (general population or NOS) Adjustment: Yes Monotherapy: no or not specified 1.70 [1.60;1.80] 1,501/9,100   59,210/718,533 60,711 9,100
ref
S14992
R61351
Robinson-Wolrath, 2016 Need for any resuscitation during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 2.20 [1.67;2.89] -/-   -/- - -
ref
S8053
R24537
Salisbury (Controls unexposed, disease free), 2016 Neonatal intensive care unit admission during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: No Monotherapy: no or not specified 2.02 [0.54;7.58] C
excluded (control group)
6/52   4/66 10 52
ref
S8071
R24580
Salisbury (Controls unexposed, sick), 2016 Neonatal intensive care unit admission during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified 7.17 [0.83;61.77] C 6/52   1/56 7 52
ref
S6107
R15971
Malm (Controls unexposed, disease free), 2015 Neonatal care unit during pregnancy (anytime or not specified) population based cohort retrospective unexposed, disease free excluded Adjustment: Yes Monotherapy: no or not specified 1.38 [1.29;1.48]
excluded (control group)
2,405/15,729   3,032/31,394 5,437 15,729
ref
S5374
R15955
Malm (Controls unexposed, sick), 2015 Neonatal care unit during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: Yes Monotherapy: no or not specified Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) 1.24 [1.14;1.35] 2,405/15,729   1,160/9,652 3,565 15,729
ref
S12947
R49133
Engelstad (Controls unexposed, disease free), 2014 Admission to the neonatal intensive care unit (NICU) during pregnancy (anytime or not specified) retrospective cohort unexposed, disease free excluded Adjustment: Yes Monotherapy: SSRI only 1.14 [0.69;1.91]
excluded (control group)
55/126   50/222 105 126
ref
S12948
R49134
Engelstad (Controls unexposed, sick), 2014 Admission to the neonatal intensive care unit (NICU) during pregnancy (anytime or not specified) retrospective cohort unexposed, sick Adjustment: No Monotherapy: SSRI only 1.17 [0.71;1.93] C 55/126   51/128 106 126
ref
S13258
R51065
Smith, 2013 Neonatal intensive care unit (NICU) 3rd trimester prospective cohort unexposed, disease free Adjustment: No Monotherapy: no or not specified 2.85 [0.27;30.62] C 1/6   4/61 5 6
ref
S5428
R20521
Colvin, 2012 Intensive care unit admissions during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 1.40 [1.26;1.55] 438/3,764   8,125/94,561 8,563 3,764
ref
S5961
R15335
Grzeskowiak a (Controls unexposed, disease free), 2012 Neonate admitted to hospital during pregnancy (anytime or not specified) retrospective cohort unexposed, disease free excluded Adjustment: Yes Monotherapy: SSRI only 2.37 [1.76;3.19]
excluded (control group)
87/221   6,114/32,004 6,201 221
ref
S5367
R15330
Grzeskowiak a (Controls unexposed, sick), 2012 Neonate admitted to hospital during pregnancy (anytime or not specified) retrospective cohort unexposed, sick Adjustment: Yes Monotherapy: SSRI only Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 1.92 [1.39;2.65] 87/221   414/1,566 501 221
ref
S5395
R16288
Klieger-Grossmann - Escitalopram, 2012 Neonatal intensive care unit admission late pregnancy prospective cohort unexposed (general population or NOS) Adjustment: No Matched Monotherapy: SSRI only 1.32 [0.59;2.94] C 14/172   12/191 26 172
ref
S5406
R15092
Calderon-Margalit, 2009 Neonatal Intensiv Care Unit (NICU) during pregnancy (anytime or not specified) prospective cohort unexposed (general population or NOS) Adjustment: Yes Monotherapy: no or not specified 1.36 [0.70;2.67] -/132   -/2,493 - 132
ref
S491
R16208
Lund (Controls unexposed, disease free), 2009 Neonatal intensive care unit admission during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: Yes Monotherapy: no or not specified 2.39 [1.69;3.39]
excluded (control group)
54/329   3,845/51,770 3,899 329
ref
S6162
R16212
Lund (Controls unexposed, sick), 2009 Neonatal intensive care unit admission during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified 2.00 [1.47;2.72] C 54/329   439/4,902 493 329
ref
S5408
R16600
Wisner (Controls unexposed, disease free), 2009 Admission to Neonatal Intensive care unit throughout pregnancy prospective cohort unexposed, disease free excluded Adjustment: No Monotherapy: no or not specified 2.77 [1.05;7.31] C
excluded (control group)
9/48   10/130 19 48
ref
S6249
R16608
Wisner (Controls unexposed, sick), 2009 Admission to Neonatal Intensive care unit throughout pregnancy prospective cohort unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 0.85 [0.19;3.67] C 9/48   3/14 12 48
ref
S7288
R21081
Maschi - Paroxetine, 2008 Neonatal Intensive Care Unit (NICU)/Special Care Nursery (SCN) admissions during pregnancy (anytime or not specified) prospective cohort unexposed (general population or NOS) Adjustment: No Matched Monotherapy: no or not specified 1.00 [0.12;8.46] C 1/58   6/348 7 58
ref
S5394
R20677
Davis, 2007 Respiratory distress syndrome and other respiratory conditions 3rd trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 1.97 [1.65;2.35] 112/874   5,300/75,219 5,412 874
ref
S15011
R61495
Lennestal, 2007 Respiratory problems (Includes a diagnosis of respiratory problems and/or use of mechanical ventilation or continuous positive airway pressure) late pregnancy population based cohort retrospective unexposed (general population or NOS) Adjustment: Yes Monotherapy: no or not specified 1.72 [1.41;2.11] 99/-   -/- - -
ref
S11220
R41289
Pearson (Controls exposed to TCA), 2007 Admission in Special care nursery of neonatal intensive care unit during pregnancy (anytime or not specified) retrospective cohort exposed to other treatment, sick excluded Adjustment: No Monotherapy: SSRI only 0.32 [0.10;1.03] C
excluded (control group)
5/42   11/37 16 42
ref
S11219
R41286
Pearson (Controls unexposed, NOS), 2007 Admission in Special care nursery of neonatal intensive care unit during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: No Monotherapy: SSRI only 1.20 [0.42;3.46] C 5/42   17/168 22 42
ref
S5989
R17674
Suri, 2007 Special care nursery admission during pregnancy (anytime or not specified) prospective cohort unexposed, disease free Adjustment: No Monotherapy: no or not specified 10.36 [0.58;186.64] C 10/48   0/19 10 48
ref
S5405
R16053
Wen, 2006 Mechanical ventilation in neonates 3 months (or more) before pregnancy or during pregnancy excluded retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Matched Monotherapy: no or not specified 1.14 [0.74;1.75]
excluded (exposition period)
34/972   87/3,878 121 972
ref
S508
R17594
Sivojelezova - Citalopram, 2005 Neonatal intensive care unit admission 3rd trimester prospective cohort unexposed (general population or NOS) Adjustment: No Matched Monotherapy: no or not specified 4.20 [1.70;10.30] 10/63   6/158 16 63
ref
S7969
R24468
Oberlander, 2004 Poor neonatal adaptation (high level of medical care and observation) during pregnancy (anytime or not specified) prospective cohort unexposed, disease free Adjustment: No Monotherapy: SSRI only 3.50 [0.65;18.85] C 7/28   2/23 9 28
ref
S7764
R22971
Suri - Fluoxetine (Controls unexposed, disease free), 2004 Neonatal Intensive Care Unit (NICU) admissions during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: No Monotherapy: SSRI only 0.52 [0.09;2.95] C
excluded (control group)
3/28   3/16 6 28
ref
S7581
R22970
Suri - Fluoxetine (Controls unexposed, sick), 2004 Neonatal Intensive Care Unit (NICU) admissions during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No Monotherapy: SSRI only Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified 0.96 [0.14;6.39] C 3/28   2/18 5 28
ref
S510
R15166
Casper, 2003 Admission to neonatal intensive care units during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 7.98 [0.42;151.51] C 7/31   0/13 7 31
ref
S5954
R15276
Costei - Paroxetine (Controls unexposed, NOS), 2002 Neonate respiratory distress 3rd trimester prospective cohort unexposed (general population or NOS) excluded Adjustment: No Matched Monotherapy: no or not specified 11.07 [0.62;197.91] C
excluded (control group)
9/55   0/27 9 55
ref
S5953
R15272
Costei - Paroxetine (Controls unexposed, sick), 2002 Neonate respiratory distress 3rd trimester prospective cohort unexposed, sick Adjustment: No Matched Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 5.09 [0.61;42.43] C 9/55   1/27 10 55
ref
S490
R15172
Chambers - Fluoxetine, 1996 Admission to a special-care nursery late pregnancy prospective cohort unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 4.74 [2.41;9.30] C 23/73   20/226 43 73
ref
Total 36 studies 1.84 [1.63;2.07] 106,889 61,231
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Lee (Controls unexposed, general pop), 2025Lee, 2025 1 1.03[0.74; 1.43]8,6071,4654%ROB confusion: moderateROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Raviv, 2025Raviv, 2025 3.07[2.59; 3.65]2,4282,3216%ROB confusion: criticalROB selection: unclearROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Cornet - SSRIs, 2024Cornet - SSRIs, 2024 2.14[1.96; 2.33]12,9257,5736%ROB confusion: moderateROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Gover, 2023Gover, 2023 1.58[0.24; 10.61]5210%ROB confusion: seriousROB selection: unclearROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Rommel, 2022Rommel, 2022 1.43[1.35; 1.51]-16,4297%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Marks - Sertraline (Controls exposed to Bupropion), 2021Marks - Sertraline, 2021 2 1.08[0.81; 1.45]4751,6535%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Ulbrich, 2021Ulbrich, 2021 2.13[1.18; 3.32]3021633%ROB confusion: seriousROB selection: unclearROB classification: moderateROB missing: moderateROB mesure: moderateROB reporting: moderate Levy, 2020Levy, 2020 8.34[3.78; 18.39]54822%ROB confusion: criticalROB selection: criticalROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Gungor (Controls unexposed, sick), 2019Gungor, 2019 3 1.41[0.33; 6.10]10401%ROB confusion: seriousROB selection: unclearROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Giardinelli (Controls unexposed, sick), 2018Giardinelli, 2018 4 0.95[0.12; 7.41]4240%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Hogue, 2017Hogue, 2017 4.90[1.30; 18.70]201171%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Bracero, 2016Bracero, 2016 12.17[2.00; 73.89]1660%ROB confusion: criticalROB selection: criticalROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Kivistö, 2016Kivistö, 2016 2.20[1.67; 2.88]2,5133585%ROB confusion: seriousROB selection: criticalROB classification: moderateROB missing: criticalROB mesure: moderateROB reporting: moderate Norby, 2016Norby, 2016 1.70[1.60; 1.80]60,7119,1007%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Robinson-Wolrath, 2016Robinson-Wolrath, 2016 2.20[1.67; 2.89]--5%ROB confusion: criticalROB selection: unclearROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: unclear Salisbury (Controls unexposed, sick), 2016Salisbury, 2016 5 7.17[0.83; 61.77]7520%ROB confusion: seriousROB selection: unclearROB classification: moderateROB missing: moderateROB mesure: moderateROB reporting: moderate Malm (Controls unexposed, sick), 2015Malm, 2015 6 1.24[1.14; 1.35]3,56515,7296%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: moderateROB mesure: moderateROB reporting: moderate Engelstad (Controls unexposed, sick), 2014Engelstad, 2014 7 1.17[0.71; 1.93]1061263%ROB confusion: criticalROB selection: criticalROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Smith, 2013Smith, 2013 2.85[0.27; 30.62]560%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Colvin, 2012Colvin, 2012 1.40[1.26; 1.55]8,5633,7646%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Grzeskowiak a (Controls unexposed, sick), 2012Grzeskowiak a, 2012 8 1.92[1.39; 2.65]5012215%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Klieger-Grossmann - Escitalopram, 2012Klieger-Grossmann - Escitalopram, 2012 1.32[0.59; 2.94]261722%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Calderon-Margalit, 2009Calderon-Margalit, 2009 1.36[0.70; 2.67]-1322%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Lund (Controls unexposed, sick), 2009Lund, 2009 9 2.00[1.47; 2.72]4933295%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Wisner (Controls unexposed, sick), 2009Wisner, 2009 10 0.85[0.19; 3.67]12481%ROB confusion: criticalROB selection: lowROB classification: lowROB missing: lowROB mesure: moderateROB reporting: moderate Maschi - Paroxetine, 2008Maschi - Paroxetine, 2008 1.00[0.12; 8.46]7580%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Davis, 2007Davis, 2007 1.97[1.65; 2.35]5,4128746%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Lennestal, 2007Lennestal, 2007 1.72[1.41; 2.11]--6%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Pearson (Controls unexposed, NOS), 2007Pearson, 2007 11 1.20[0.42; 3.46]22421%ROB confusion: unclearROB selection: criticalROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate Suri, 2007Suri, 2007 10.36[0.58; 186.64]10480%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Sivojelezova - Citalopram, 2005Sivojelezova - Citalopram, 2005 4.20[1.70; 10.30]16631%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Oberlander, 2004Oberlander, 2004 3.50[0.65; 18.85]9280%ROB confusion: criticalROB selection: criticalROB classification: lowROB missing: lowROB mesure: moderateROB reporting: moderate Suri - Fluoxetine (Controls unexposed, sick), 2004Suri - Fluoxetine, 2004 12 0.96[0.14; 6.39]5280%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Casper, 2003Casper, 2003 7.98[0.42; 151.51]7310%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Costei - Paroxetine (Controls unexposed, sick), 2002Costei - Paroxetine, 2002 13 5.09[0.61; 42.43]10550%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: criticalROB reporting: moderate Chambers - Fluoxetine, 1996Chambers - Fluoxetine, 1996 4.74[2.41; 9.30]43732%ROB confusion: criticalROB selection: criticalROB classification: lowROB missing: lowROB mesure: moderateROB reporting: moderate Total (36 studies) I2 = 86% 1.84[1.63; 2.07]106,88961,2310.250.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, general pop; 2: Controls exposed to Bupropion; 3: Controls unexposed, sick; 4: Controls unexposed, sick; 5: Controls unexposed, sick; 6: Controls unexposed, sick; 7: Controls unexposed, sick; 8: Controls unexposed, sick; 9: Controls unexposed, sick; 10: Controls unexposed, sick; 11: Controls unexposed, NOS; 12: Controls unexposed, sick; 13: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.84[1.63; 2.07]106,88961,23186%NALee (Controls unexposed, general pop), 2025 Raviv, 2025 Cornet - SSRIs, 2024 Gover, 2023 Rommel, 2022 Marks - Sertraline (Controls exposed to Bupropion), 2021 Ulbrich, 2021 Levy, 2020 Gungor (Controls unexposed, sick), 2019 Giardinelli (Controls unexposed, sick), 2018 Hogue, 2017 Bracero, 2016 Kivistö, 2016 Norby, 2016 Robinson-Wolrath, 2016 Salisbury (Controls unexposed, sick), 2016 Malm (Controls unexposed, sick), 2015 Engelstad (Controls unexposed, sick), 2014 Smith, 2013 Colvin, 2012 Grzeskowiak a (Controls unexposed, sick), 2012 Klieger-Grossmann - Escitalopram, 2012 Calderon-Margalit, 2009 Lund (Controls unexposed, sick), 2009 Wisner (Controls unexposed, sick), 2009 Maschi - Paroxetine, 2008 Davis, 2007 Lennestal, 2007 Pearson (Controls unexposed, NOS), 2007 Suri, 2007 Sivojelezova - Citalopram, 2005 Oberlander, 2004 Suri - Fluoxetine (Controls unexposed, sick), 2004 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 Chambers - Fluoxetine, 1996 36 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 2.04[1.75; 2.36]101,67826,46084%NALee (Controls unexposed, general pop), 2025 Raviv, 2025 Cornet - SSRIs, 2024 Gover, 2023 Ulbrich, 2021 Levy, 2020 Hogue, 2017 Kivistö, 2016 Norby, 2016 Robinson-Wolrath, 2016 Smith, 2013 Colvin, 2012 Klieger-Grossmann - Escitalopram, 2012 Calderon-Margalit, 2009 Maschi - Paroxetine, 2008 Davis, 2007 Lennestal, 2007 Pearson (Controls unexposed, NOS), 2007 Suri, 2007 Sivojelezova - Citalopram, 2005 Oberlander, 2004 Chambers - Fluoxetine, 1996 22 unexposed, sickunexposed, sick 1.51[1.29; 1.76]4,73633,11858%NARommel, 2022 Gungor (Controls unexposed, sick), 2019 Giardinelli (Controls unexposed, sick), 2018 Bracero, 2016 Salisbury (Controls unexposed, sick), 2016 Malm (Controls unexposed, sick), 2015 Engelstad (Controls unexposed, sick), 2014 Grzeskowiak a (Controls unexposed, sick), 2012 Lund (Controls unexposed, sick), 2009 Wisner (Controls unexposed, sick), 2009 Suri - Fluoxetine (Controls unexposed, sick), 2004 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 13 exposed to other treatment, sickexposed to other treatment, sick 1.08[0.81; 1.44]4751,653 -NAMarks - Sertraline (Controls exposed to Bupropion), 2021 1 Tags Adjustment   - No  - No 2.28[1.74; 2.99]17,2708,29179%NARaviv, 2025 Gover, 2023 Levy, 2020 Gungor (Controls unexposed, sick), 2019 Giardinelli (Controls unexposed, sick), 2018 Bracero, 2016 Salisbury (Controls unexposed, sick), 2016 Engelstad (Controls unexposed, sick), 2014 Smith, 2013 Colvin, 2012 Klieger-Grossmann - Escitalopram, 2012 Lund (Controls unexposed, sick), 2009 Wisner (Controls unexposed, sick), 2009 Maschi - Paroxetine, 2008 Davis, 2007 Pearson (Controls unexposed, NOS), 2007 Suri, 2007 Sivojelezova - Citalopram, 2005 Oberlander, 2004 Suri - Fluoxetine (Controls unexposed, sick), 2004 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 Chambers - Fluoxetine, 1996 23   - Yes  - Yes 1.64[1.43; 1.88]89,61952,94091%NALee (Controls unexposed, general pop), 2025 Cornet - SSRIs, 2024 Rommel, 2022 Marks - Sertraline (Controls exposed to Bupropion), 2021 Ulbrich, 2021 Hogue, 2017 Kivistö, 2016 Norby, 2016 Robinson-Wolrath, 2016 Malm (Controls unexposed, sick), 2015 Grzeskowiak a (Controls unexposed, sick), 2012 Calderon-Margalit, 2009 Lennestal, 2007 13 MatchedMatched 3.00[1.36; 6.59]11845160%NAGover, 2023 Levy, 2020 Klieger-Grossmann - Escitalopram, 2012 Maschi - Paroxetine, 2008 Sivojelezova - Citalopram, 2005 Costei - Paroxetine (Controls unexposed, sick), 2002 6 Monotherapy   - no or not specified  - no or not specified 2.07[1.75; 2.45]94,59540,55288%NARaviv, 2025 Cornet - SSRIs, 2024 Gover, 2023 Ulbrich, 2021 Levy, 2020 Giardinelli (Controls unexposed, sick), 2018 Bracero, 2016 Norby, 2016 Salisbury (Controls unexposed, sick), 2016 Malm (Controls unexposed, sick), 2015 Smith, 2013 Colvin, 2012 Calderon-Margalit, 2009 Lund (Controls unexposed, sick), 2009 Wisner (Controls unexposed, sick), 2009 Maschi - Paroxetine, 2008 Davis, 2007 Lennestal, 2007 Suri, 2007 Sivojelezova - Citalopram, 2005 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 Chambers - Fluoxetine, 1996 23   - SSRI only  - SSRI only 1.63[1.33; 1.99]11,81919,02663%NALee (Controls unexposed, general pop), 2025 Rommel, 2022 Gungor (Controls unexposed, sick), 2019 Hogue, 2017 Kivistö, 2016 Robinson-Wolrath, 2016 Engelstad (Controls unexposed, sick), 2014 Grzeskowiak a (Controls unexposed, sick), 2012 Klieger-Grossmann - Escitalopram, 2012 Pearson (Controls unexposed, NOS), 2007 Oberlander, 2004 Suri - Fluoxetine (Controls unexposed, sick), 2004 12   - substance alone among all Antidep ( ...  - substance alone among all Antidep (SSRI, SNRI, ...) 1.08[0.81; 1.44]4751,653 -NAMarks - Sertraline (Controls exposed to Bupropion), 2021 1 Unexposed sick   - intermediate history of illness/tre ...  - intermediate history of illness/treatment (3-12 months before pregnancy) 1.34[1.16; 1.54]3,56532,15887%NARommel, 2022 Malm (Controls unexposed, sick), 2015 2   - old history of illness/treatment (> ...  - old history of illness/treatment (> 12 months before pregnancy) or not specified 1.98[1.48; 2.66]5154490%NAGungor (Controls unexposed, sick), 2019 Salisbury (Controls unexposed, sick), 2016 Lund (Controls unexposed, sick), 2009 Suri - Fluoxetine (Controls unexposed, sick), 2004 4   - recent illness/treatment (during o ...  - recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 1.89[1.39; 2.57]5343790%NAGiardinelli (Controls unexposed, sick), 2018 Grzeskowiak a (Controls unexposed, sick), 2012 Wisner (Controls unexposed, sick), 2009 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 5 All studiesAll studies 1.84[1.63; 2.07]106,88961,23186%NALee (Controls unexposed, general pop), 2025 Raviv, 2025 Cornet - SSRIs, 2024 Gover, 2023 Rommel, 2022 Marks - Sertraline (Controls exposed to Bupropion), 2021 Ulbrich, 2021 Levy, 2020 Gungor (Controls unexposed, sick), 2019 Giardinelli (Controls unexposed, sick), 2018 Hogue, 2017 Bracero, 2016 Kivistö, 2016 Norby, 2016 Robinson-Wolrath, 2016 Salisbury (Controls unexposed, sick), 2016 Malm (Controls unexposed, sick), 2015 Engelstad (Controls unexposed, sick), 2014 Smith, 2013 Colvin, 2012 Grzeskowiak a (Controls unexposed, sick), 2012 Klieger-Grossmann - Escitalopram, 2012 Calderon-Margalit, 2009 Lund (Controls unexposed, sick), 2009 Wisner (Controls unexposed, sick), 2009 Maschi - Paroxetine, 2008 Davis, 2007 Lennestal, 2007 Pearson (Controls unexposed, NOS), 2007 Suri, 2007 Sivojelezova - Citalopram, 2005 Oberlander, 2004 Suri - Fluoxetine (Controls unexposed, sick), 2004 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 Chambers - Fluoxetine, 1996 360.250.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-3.54.11.8020.000Lee (Controls unexposed, general pop), 2025Raviv, 2025Cornet - SSRIs, 2024Gover, 2023Rommel, 2022Marks - Sertraline (Controls exposed to Bupropion), 2021Ulbrich, 2021Levy, 2020Gungor (Controls unexposed, sick), 2019Giardinelli (Controls unexposed, sick), 2018Hogue, 2017Bracero, 2016Kivistö, 2016Norby, 2016Robinson-Wolrath, 2016Salisbury (Controls unexposed, sick), 2016Malm (Controls unexposed, sick), 2015Engelstad (Controls unexposed, sick), 2014Smith, 2013Colvin, 2012Grzeskowiak a (Controls unexposed, sick), 2012Klieger-Grossmann - Escitalopram, 2012Calderon-Margalit, 2009Lund (Controls unexposed, sick), 2009Wisner (Controls unexposed, sick), 2009Maschi - Paroxetine, 2008Davis, 2007Lennestal, 2007Pearson (Controls unexposed, NOS), 2007Suri, 2007Sivojelezova - Citalopram, 2005Oberlander, 2004Suri - Fluoxetine (Controls unexposed, sick), 2004Casper, 2003Costei - Paroxetine (Controls unexposed, sick), 2002Chambers - Fluoxetine, 1996

Asymetry test p-value = 0.0068 (by Egger's regression)

slope=0.4326 (0.0485); intercept=0.9127 (0.5378); t=1.6972; p=0.0068

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 5954, 7764, 11220, 491, 5408, 5961, 12947, 6107, 8053, 7921, 12918, 8158, 18442

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.95[1.71; 2.22]117,47043,11284%NALee (Controls unexposed, general pop), 2025 Raviv, 2025 Cornet - SSRIs, 2024 Gover, 2023 Ulbrich, 2021 Levy, 2020 Gungor (Controls unexposed, disease free), 2019 Giardinelli (Controls unexposed, disease free), 2018 Hogue, 2017 Kivistö, 2016 Norby, 2016 Robinson-Wolrath, 2016 Salisbury (Controls unexposed, disease free), 2016 Malm (Controls unexposed, disease free), 2015 Engelstad (Controls unexposed, disease free), 2014 Smith, 2013 Colvin, 2012 Grzeskowiak a (Controls unexposed, disease free), 2012 Klieger-Grossmann - Escitalopram, 2012 Calderon-Margalit, 2009 Lund (Controls unexposed, disease free), 2009 Wisner (Controls unexposed, disease free), 2009 Maschi - Paroxetine, 2008 Davis, 2007 Lennestal, 2007 Pearson (Controls unexposed, NOS), 2007 Suri, 2007 Sivojelezova - Citalopram, 2005 Oberlander, 2004 Suri - Fluoxetine (Controls unexposed, disease free), 2004 Costei - Paroxetine (Controls unexposed, NOS), 2002 Chambers - Fluoxetine, 1996 32 unexposed, sick controlsunexposed, sick controls 1.51[1.29; 1.76]4,73633,11858%NARommel, 2022 Gungor (Controls unexposed, sick), 2019 Giardinelli (Controls unexposed, sick), 2018 Bracero, 2016 Salisbury (Controls unexposed, sick), 2016 Malm (Controls unexposed, sick), 2015 Engelstad (Controls unexposed, sick), 2014 Grzeskowiak a (Controls unexposed, sick), 2012 Lund (Controls unexposed, sick), 2009 Wisner (Controls unexposed, sick), 2009 Suri - Fluoxetine (Controls unexposed, sick), 2004 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 13 exposed to other treatment, sick controlsexposed to other treatment, sick controls 0.88[0.59; 1.33]5623,20036%NALee (Controls exposed to TCAs), 2025 Marks - Sertraline (Controls exposed to Bupropion), 2021 Gungor (Controls exposed to Mirtazapine), 2019 Pearson (Controls exposed to TCA), 2007 40.510.01.0

Umbrella review (other published meta-analyses)

Published MAControlPeriodTE95% CIn exposedkI2 Lattimore - SSRI (Neonatal intensive care unit)Lattimore - SSRI (Neonatal intensive care unit) 3.30[1.45; 7.54]-U,GPunexposed (general population or NOS)Anyduring pregnancy (anytime or not specified)studies TTT-9 McDonagh - SSRI (Respiratory distress)McDonagh - SSRI (Respiratory distress) 1.91[1.63; 2.24]NA-U,GPunexposed (general population or NOS)Latelate pregnancystudies TTT3 Wang - SSRI (Respiratory distress)Wang - SSRI (Respiratory distress) 1.39[0.53; 3.64]84%-Wwhatever (meta-analysis)T33rd trimesterstudies TTT3 metaPregmetaPreg 1.84[1.63; 2.07]86%61,231----Lee (Controls unexposed, general pop), 2025 Raviv, 2025 Cornet - SSRIs, 2024 Gover, 2023 Rommel, 2022 Marks - Sertraline (Controls exposed to Bupropion), 2021 Ulbrich, 2021 Levy, 2020 Gungor (Controls unexposed, sick), 2019 Giardinelli (Controls unexposed, sick), 2018 Hogue, 2017 Bracero, 2016 Kivistö, 2016 Norby, 2016 Robinson-Wolrath, 2016 Salisbury (Controls unexposed, sick), 2016 Malm (Controls unexposed, sick), 2015 Engelstad (Controls unexposed, sick), 2014 Smith, 2013 Colvin, 2012 Grzeskowiak a (Controls unexposed, sick), 2012 Klieger-Grossmann - Escitalopram, 2012 Calderon-Margalit, 2009 Lund (Controls unexposed, sick), 2009 Wisner (Controls unexposed, sick), 2009 Maschi - Paroxetine, 2008 Davis, 2007 Lennestal, 2007 Pearson (Controls unexposed, NOS), 2007 Suri, 2007 Sivojelezova - Citalopram, 2005 Oberlander, 2004 Suri - Fluoxetine (Controls unexposed, sick), 2004 Casper, 2003 Costei - Paroxetine (Controls unexposed, sick), 2002 Chambers - Fluoxetine, 1996 360.510.01.0